Ategra Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-6,450
Closed -$313K – 81
2024
Q1
$313K Hold
6,450
– – 0.14% 79
2023
Q4
$321K Sell
6,450
-499
-7% -$24.4K 0.14% 75
2023
Q3
$373K Sell
6,949
-518
-7% -$27.6K 0.2% 73
2023
Q2
$402K Hold
7,467
– – 0.22% 66
2023
Q1
$406K Hold
7,467
– – 0.22% 68
2022
Q4
$362K Sell
7,467
-771
-9% -$33.8K 0.18% 72
2022
Q3
$313K Sell
8,238
-116
-1% -$5.17K 0.16% 77
2022
Q2
$418K Sell
8,354
-527
-6% -$28K 0.21% 70
2022
Q1
$456K Sell
8,881
-1,384
-13% -$71.5K 0.2% 76
2021
Q4
$514K Sell
10,265
-112
-1% -$5.54K 0.22% 71
2021
Q3
$500K Sell
10,377
-1,135
-10% -$57.7K 0.24% 71
2021
Q2
$606K Sell
11,512
-817
-7% -$42.6K 0.29% 65
2021
Q1
$610K Buy
12,329
+824
+7% +$39.6K 0.34% 56
2020
Q4
$559K Buy
11,505
+981
+9% +$48.4K 0.39% 52
2020
Q3
$528K Hold
10,524
– – 0.47% 49
2020
Q2
$537K Hold
10,524
– – 0.51% 42
2020
Q1
$460K Hold
10,524
– – 0.54% 38
2019
Q4
$528K Buy
10,524
+172
+2% +$8.06K 0.44% 44
2019
Q3
$480K Buy
10,352
+743
+8% +$32K 0.44% 48
2019
Q2
$416K Sell
9,609
-279
-3% -$11.9K 0.39% 58
2019
Q1
$438K Buy
+9,888
New +$424K 0.43% 49

Other funds holding SNY

Ategra Capital Management's SNY Position: Q2 2024 in Review

Ategra Capital Management sold out of Sanofi (SNY) in Q2 2024, closing a stake of 6,450 shares — an estimated $313K sold.

Ategra Capital Management first reported a position in SNY in Q1 2019 and held it in 21 quarters. The position peaked at $610K in Q1 2021. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Ategra Capital Management reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • Ategra Capital Management sold 6,450 Sanofi shares in Q2 2024, an estimated $313K.
  • Ategra Capital Management first reported a position in Sanofi in Q1 2019 and held it in 21 quarters.
  • Ategra Capital Management's Sanofi position peaked at $610K in Q1 2021.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.